An Observational Drug Utilization Study of Asenapine in the United Kingdom (P08308)

Summary

This study is designed to describe asenapine prescribing patterns in the United Kingdom (UK) during the post-approval period under conditions of usual practice. The use of asenapine in Bipolar Disorder and other indications will be described. To provide epidemiological and clinical perspective, use of aripiprazole and other comparator drugs will be described.

Conditions

• Bipolar Disorder

Interventions

DRUG

Asenapine

Asenapine prescribed as recorded in the CPRD in the UK

DRUG

Aripiprazole

Aripiprazole prescribed as recorded in the CPRD in the UK

DRUG

Quetiapine

Quetiapine prescribed as recorded in the CPRD in the UK

DRUG

Risperidone

Risperidone prescribed as recorded in the CPRD in the UK

DRUG

Olanzapine

Olanzapine prescribed as recorded in the CPRD in the UK

DRUG

Ziprasidone

Ziprasidone prescribed as recorded in the CPRD in the UK

DRUG

Iloperidone

Iloperidone prescribed as recorded in the CPRD in the UK

DRUG

Paliperidone

Paliperidone prescribed as recorded in the CPRD in the UK

DRUG

Lurasidone

Lurasidone prescribed as recorded in the CPRD in the UK

DRUG

Clozapine

Clozapine prescribed as recorded in the CPRD in the UK

DRUG

Amisulpride

Amisulpride prescribed as recorded in the CPRD in the UK

DRUG

Sertindole

Sertindole prescribed as recorded in the CPRD in the UK

DRUG

Zotepine

Zotepine prescribed as recorded in the CPRD in the UK

Sponsors & Collaborators

• Organon and Co

  lead INDUSTRY

Principal Investigators

• Medical Director · Merck Sharp & Dohme LLC

Eligibility

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2013-04-01

Primary Completion

2017-12-21

Completion

2017-12-21